How Does HIV Cause AIDS?
The DOI matches its Crossref record; 129 of the 130 references it cites were found in a registry or an index.
Abstract
Many questions have been posed about acquired immunodeficiency syndrome (AIDS) pathogenesis. Is human immunodeficiency virus (HIV) both necessary and sufficient to cause AIDS? Is AIDS essentially an autoimmune disease, triggering apoptosis, or is virus infection the cause of T helper lymphocyte depletion? What is the significance of HIV tropism and the role of macrophages and dendritic cells in AIDS? Is there viral latency and why is there usually a long period between infection and AIDS? Is HIV variation a crucial aspect of its pathogenesis and, if so, do virulent strains emerge? Although this article provides few definitive answers, it aims to focus commentary on salient points. Overall, it is increasingly evident that both the tropism and burden of HIV infection correlate closely with the manifestations of disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Barré-Sinoussi, F., Chermann, J. C., Rey, F., Nugeyre, M. T., Chamaret, S., Gruest, J., Dauguet, C., Axler-Blin, C., Vézinet-Brun, F., Rouzioux, C., et al. (1983) · Science · doi:10.1126/science.6189183 · Cited by 7,038
The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus
Dalgleish, A. G., Beverley, P. C. L., Clapham, P. R., Crawford, D. H., Greaves, M. F., & Weiss, R. A. (1984) · Nature · doi:10.1038/312763a0 · Cited by 3,533
Self-citationGottlieb, M. S., Schroff, R., Schanker, H. M., Weisman, J. D., Fan, P. T., Wolf, R. A., & Saxon, A. (1981) · New England Journal of Medicine · doi:10.1056/nejm198112103052401 · Cited by 2,728
T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV
Klatzmann, D., Champagne, E., Chamaret, S., Gruest, J., Guetard, D., Hercend, T., Gluckman, J.-C., & Montagnier, L. (1984) · Nature · doi:10.1038/312767a0 · Cited by 2,436
Jonjić, S., Mutter, W., Weiland, F., Reddehase, M. J., & Koszinowski, U. H. (1989) · The Journal of experimental medicine · doi:10.1084/jem.169.4.1199 · Cited by 2,105
Pantaleo, G., Graziosi, C., Demarest, J. F., Butini, L., Montroni, M., Fox, C. H., Orenstein, J. M., Kotler, D. P., & Fauci, A. S. (1993) · Nature · doi:10.1038/362355a0 · Cited by 1,808
The Role of Mononuclear Phagocytes in HTLV-III/LAV Infection
Gartner, S., Markovits, P., Markovitz, D. M., Kaplan, M. H., Gallo, R. C., & Popovic, M. (1986) · Science · doi:10.1126/science.3014648 · Cited by 1,807
Embretson, J., Zupancic, M., Ribas, J. L., Burke, A., Racz, P., Tenner-Racz, K., & Haase, A. T. (1993) · Nature · doi:10.1038/362359a0 · Cited by 1,419
A TH1→TH2 switch is a critical step in the etiology of HIV infection
Clerici, M., & Shearer, G. M. (1993) · Immunology Today · doi:10.1016/0167-5699(93)90208-3 · Cited by 1,390
High Levels of HIV-1 in Plasma During All Stages of Infection Determined By Competitive PCR
Piatak, M., Saag, M. S., Yang, L. C., Clark, S. J., Kappes, J. C., Luk, K.-C., Hahn, B. H., Shaw, G. M., & Lifson, J. D. (1993) · Science · doi:10.1126/science.8096089 · Cited by 1,237
Research works printed but not linked: 13
- ARMSTRONG, J. A., IMMUNOLOGY TODAY 6: 121 (1985).
- ASJO, B, LANCET 2: 234 (1986).
- COLLIN M THESIS U OXFORD (1992).
- GOUGEON, M. L., COMPTES RENDUS DE L ACADEMIE DES SCIENCES SERIE III-SCIENCES DE LA VIE-LIFE SCIENCES 312: 529 (1991).
- HO, D. D., NEW ENGLAND JOURNAL OF MEDICINE 321: 1621 (1989). · DOI · Paper page
- HUMPHREY, J.H., VIRUS-LIKE PARTICLES IN AIDS-RELATED LYMPHADENOPATHY, LANCET 2: 643 (1984).
- MACETONIA, S.E., IMMUNOLOGY 75: 576 (1992).
- MIEDEMA, F, IMMUNODEFIC REV 3: 173 (1992).
- Mulder D. abstract PoC 4021 VIII International AIDS Conference (1992).
- Oka S. abstract PoC 4752 VIII International AIDS Conference (1992).
- SHEPPARD, H. W., JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY 5: 143 (1992).
- VALENTIN A THESIS KAROLINSKA I (1992).
- Weiss, R. A., The Retroviridae 2: 1 (1993).
Cited by
Items 201–300 of 684
EVOLUTIONARY BIOLOGY OF HUMAN IMMUNODEFICIENCY VIRUS
Brown, A., & Holmes, E. C. (1994) · Annual Review of Ecology and Systematics · doi:10.1146/annurev.es.25.110194.001015 · Cited by 27
The efficient synthesis of (3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-ol and its isomers
Kulkarni, M. G., Shaikh, Y. B., Borhade, A. S., Dhondge, A. P., Chavhan, S. W., Desai, M. P., Birhade, D. R., Dhatrak, N. R., & Gannimani, R. (2010) · Tetrahedron Asymmetry · doi:10.1016/j.tetasy.2010.08.005 · Cited by 26
Sevenich, A., Liu, G., Arduengo, A. J., Gupton, B. F., & Opatz, T. (2016) · The Journal of Organic Chemistry · doi:10.1021/acs.joc.6b02588 · Cited by 26
Lucas, S. B. (1993) · Journal of Clinical Pathology · doi:10.1136/jcp.46.12.1071 · Cited by 26
Cooper, D. A., Penny, R., & Symonds, G. P. (1999) · Human Gene Therapy · doi:10.1089/10430349950018067 · Cited by 26
Comparative Biology and Pathogenesis of AIDS and Hepatitis B Viruses: Related but Different
Hilleman, M. R. (1994) · AIDS Research and Human Retroviruses · doi:10.1089/aid.1994.10.1409 · Cited by 26
Induction of CD4+ T cell depletion in mice doubly transgenic for HIV gp120 and human CD4
Finco, O., Nuti, S., Magistris, M. T. D., Mangiavacchi, L., Aiuti, A., Forte, P., Fantoni, A., van der Putten, H., & Abrignani, S. (1997) · European Journal of Immunology · doi:10.1002/eji.1830270604 · Cited by 26
Clementi, M., Menzo, S., BAGNARELLI, P., Valenza, A., Paolucci, S., Sampaolesi, R., Manzin, A., & Varaldo, P. E. (1996) · Clinical Microbiology Reviews · doi:10.1128/cmr.9.2.135 · Cited by 30
“In agreement with biological, immunological, and molecular evidence, the pathogenesis of HIV-1 infection is depicted, at present, as a multistep process (51); a multitude of viral and host factors potentially involved in infection progression have been studied in the last few years in vitro and in vivo (51, 64, 125, 1…”
BackgroundThe Values of CD4 Count, among HIV Positive Patients in FMC Owerri
Obeagu, E. I., Obeagu, G. U., & Okpara, M. O. (2015) · Cited by 24
Multiobjective optimization to a TB-HIV/AIDS coinfection optimal control problem
Denysiuk, R., Silva, C. J., & Torres, D. F. M. (2017) · Computational and Applied Mathematics · doi:10.1007/s40314-017-0438-9 · Cited by 24
Mirzohreh, S., Safarpour, H., Pagheh, A. S., Bangoura, B., Barac, A. M., & Ahmadpour, E. (2022) · Parasites & Vectors · doi:10.1186/s13071-022-05432-2 · Cited by 27
Aptamers: A prospective tool for infectious diseases diagnosis
Chen, J., Zhou, J., Peng, Y., Xie, Y., & Xiao, Y. (2022) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.24725 · Cited by 24
Concepts for the design of anti-HIV nucleoside prodrugs for treating cephalic HIV infection
Wiebe, L. I., & Knaus, E. E. (1999) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(99)00020-4 · Cited by 24
Immunobiologic consequences of assist devices
Itescu, S., Schuster, M., Burke, E. M., Ankersmit, H. J., Kocher, A. A., Deng, M. C.-H. K., John, R., & Lietz, K. (2003) · Cardiology Clinics · doi:10.1016/s0733-8651(02)00135-2 · Cited by 24
“The development of defects in T-cell immunity in LVAD recipients is reminiscent of another disorder of acquired immune dysfunction, infection with the human immunodeficiency virus type 1 (HIV-1) [36].”
BackgroundPLANTAR VERRUCAE AND HIV INFECTION
Barbosa, P. (1998) · Clinics in Podiatric Medicine and Surgery · doi:10.1016/s0891-8422(23)01051-0 · Cited by 24
Duus, K., Miller, E. D., Smith, J. A., Kovalev, G. I., & Su, L. (2001) · Journal of Virology · doi:10.1128/jvi.75.8.3916-3924.2001 · Cited by 24
Mittler, J. E., Levin, B. R., & Antia, R. (1996) · Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology · doi:10.1097/00042560-199607000-00003 · Cited by 26
Chaudhari, S. B., Kumar, A., Mankar, V. H., Banerjee, S., Kumar, D., Mubarak, N. M., & Dehghani, M. H. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e32434 · Cited by 23
Yang, W., Zhou, J.-Y., Chen, L., Ao, M., Sun, S., Aiyetan, P., Simmons, A., Zhang, H., & Jackson, J. B. (2014) · Clinical Proteomics · doi:10.1186/1559-0275-11-9 · Cited by 25
Hydration Analysis of Antiviral Agent AZT by Means of DFT and MP2 Calculations
Palafox, M. A., & Talaya, J. (2010) · The Journal of Physical Chemistry B · doi:10.1021/jp1048452 · Cited by 23
Tenner‐Racz, K., von Stemm, A., Gühlk, B., Schmitz, J. E., & Rácz, P. (1994) · Research in Virology · doi:10.1016/s0923-2516(07)80020-3 · Cited by 23
Buratti, E., Tisminetzky, S. G., Scodeller, E. S., & Baralle, F. E. (1996) · Journal of Immunological Methods · doi:10.1016/0022-1759(96)00097-x · Cited by 23
How HIV-1 causes AIDS: implications for prevention and treatment
Foster, H. D. (2004) · Medical Hypotheses · doi:10.1016/j.mehy.2003.12.009 · Cited by 22
Immunological and virological markers of HIV-disease progression
Zeller, J. M., McCain, N. L., & Swanson, B. A. (1996) · Journal of the Association of Nurses in AIDS Care · doi:10.1016/s1055-3290(96)80034-3 · Cited by 22
Fidanza, N. G., Suvire, F. D., Sosa, G. L., Lobayan, R. M., Enriz, R. D., & Peruchena, N. M. (2001) · Journal of Molecular Structure THEOCHEM · doi:10.1016/s0166-1280(01)00346-3 · Cited by 22
Chen, H., He, J., Fong, S. E., Wilcox, G. E., & Wood, C. A. (2000) · Journal of Virology · doi:10.1128/jvi.74.6.2703-2713.2000 · Cited by 22
“Studies of these accessory genes have suggested that most of them are involved in viral replication and pathogenesis (19, 33, 39, 42, 44, 46, 57).”
BackgroundCardiovascular involvement in AIDS
Michaels, A. D., Lederman, R. J., MACGREGOR, J., & CHEITLIN, M. (1997) · Current Problems in Cardiology · doi:10.1016/s0146-2806(97)80013-8 · Cited by 22
Sun, L., Ely, J. A., Gerlach, W. L., & Symonds, G. P. (1997) · Molecular Biotechnology · doi:10.1007/bf02740815 · Cited by 22
Sijstermans, E., Cheung, K. L., Goossens, A. J. M., Conde, R., Rodríguez, J. L. G., & Hiligsmann, M. (2020) · Journal of Medical Economics · doi:10.1080/13696998.2020.1735399 · Cited by 21
Interfering with retrotransposition by two types of CRISPR effectors: Cas12a and Cas13a
Zhang, N., Jing, X., Liu, Y., Chen, M., Zhu, X., Jiang, J., Wang, H., Li, X., & Hao, P. (2020) · Cell Discovery · doi:10.1038/s41421-020-0164-0 · Cited by 23
Management of Psoriasis Patients with Serious Infectious Diseases
Megna, M., Lauletta, G., Tommasino, N., Salsano, A., Battista, T., Ruggiero, A., Martora, F., & Potestio, L. (2024) · Advances in Therapy · doi:10.1007/s12325-024-02873-2 · Cited by 24
“Human immunodeficiency viruses (HIV-1 and HIV-2) belong to the genus Lentivirus , and the infection that they cause, if left untreated, is responsible for acquired immunodeficiency syndrome (AIDS) [65].”
BackgroundPharmaceutical Approaches to HIV Treatment and Prevention
Yavuz, B., Morgan, J. L., Showalter, L., Crakes, K. R., Dandekar, S., Herrera, C., LiWang, P. J., & Kaplan, D. L. (2018) · Advanced Therapeutics · doi:10.1002/adtp.201800054 · Cited by 24
Have Cells Harboring the HIV Reservoir Been Immunoedited?
Huang, S.-H., McCann, C. D., Mota, T. M., Wang, C., Lipkin, S. M., & Jones, R. B. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01842 · Cited by 24
Drug–drug interactions in HIV positive cancer patients
Flepisi, B. T., Bouic, P. J., Sissolak, G., & Rosenkranz, B. (2014) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2014.04.010 · Cited by 22
Moyle, G. J. (1996) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.5.2.155 · Cited by 21
Fujii, Y. R., Otake, K., Tashiro, M., & Adachi, A. (1996) · Journal of General Virology · doi:10.1099/0022-1317-77-12-2943 · Cited by 24
“Recent data suggest that T cell killing by HIV-1 infection is a direct result of T cell destruction (Miedema et al., 1990; Weiss, 1993), and not of a failure of T cell replacement (Ho et al.”
BackgroundVaccination against the feline immunodeficiency virus: The road not taken
Lecollinet, S., & Richardson, J. P. (2007) · Comparative Immunology Microbiology and Infectious Diseases · doi:10.1016/j.cimid.2007.07.007 · Cited by 21
Buratti, E., Tisminetzky, S. G., D'AGARO, P., & Baralle, F. E. (1997) · Journal of Virology · doi:10.1128/jvi.71.3.2457-2462.1997 · Cited by 21
Thang, P. H., Ruffin, N., Brodin, D., Réthi, B., Cam, P. D., Hiển, N. T., Lopalco, L., Vivar, N., & Chiodi, F. (2010) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2010.02241.x · Cited by 22
Nandi, U., Das, A., Roy, B., Choudhury, H., Gorain, B., & Pal, T. K. (2012) · Drug Testing and Analysis · doi:10.1002/dta.419 · Cited by 22
CD8 T Cell Epitope Distribution in Viruses Reveals Patterns of Protein Biosynthesis
Diez-Rivero, C. M., & Reche, P. A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0043674 · Cited by 23
Bibiana, N. E., Emmanuel, P., Amos, D., Ramsey, Y. M., & Abdullahi, I. N. (2018) · Medical Journal of Zambia · doi:10.55320/mjz.45.1.118 · Cited by 20
Patel, M., Bacheler, L. T., Rayner, M. M., Cordova, B. C., Klabe, R. M., Erickson‐Viitanen, S., & Seitz, S. P. (1998) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(98)00119-x · Cited by 20
Parnes, O. S. (2003) · Studies in History and Philosophy of Science Part C Studies in History and Philosophy of Biological and Biomedical Sciences · doi:10.1016/s1369-8486(03)00052-9 · Cited by 22
Jackson, R. (1997) · Journal of Pharmacokinetics and Biopharmaceutics · doi:10.1023/a:1025781801322 · Cited by 20
HIV Type 1 Nef Perturbs Eye Lens Development in Transgenic Mice
Dickie, P. (1996) · AIDS Research and Human Retroviruses · doi:10.1089/aid.1996.12.177 · Cited by 20
Early Stages of Feline Immunodeficiency Virus Infection in Lymph Nodes and Spleen
Bach, J., Hurtrel, M., Chakrabarti, L. A., Ganière, J., Montagnier, L., & Hurtrel, B. (1994) · AIDS Research and Human Retroviruses · doi:10.1089/aid.1994.10.1731 · Cited by 20
Surface structured liposomes for site specific delivery of an antiviral agent-indinavir
Dubey, V., Nahar, M., Mishra, D. K., Mishra, P. K., & Jain, N. K. (2010) · Journal of drug targeting · doi:10.3109/1061186x.2010.499460 · Cited by 19
Dependent HIV incidences in back‐projection of AIDS incidence data
Becker, N. G., & Xu, C. (1994) · Statistics in Medicine · doi:10.1002/sim.4780131907 · Cited by 19
Semenya, S. S., Potgieter, M. J., & Erasmus, L. J. C. (2013) · Journal of Medicinal Plants Research · doi:10.5897/jmpr12.727 · Cited by 19
“Human immunodeficiency virus/acquired immune deficiency syndrome (HIV/AIDS) reduces progressively the effectiveness of the immune system and leaves the patient susceptible to opportunistic diseases (Weiss, 1993).”
BackgroundTreatment of cytomegalovirus retinitis with an intraocular sustained-release ganciclovir implant
Muccioli, C., & Belfort, R. (2000) · Brazilian Journal of Medical and Biological Research · doi:10.1590/s0100-879x2000000700008 · Cited by 19
Xu, C., Liu, Z., Pang, Y., & Saifullah, S. (2022) · Chaos Solitons & Fractals · doi:10.1016/j.chaos.2022.112662 · Cited by 18
Li, B., Niu, B., Chen, L., Wei, Z., Huang, T., Jiang, M., Lu, J., Zheng, M.-Y., Kong, X., & Cai, Y. (2013) · PLoS ONE · doi:10.1371/journal.pone.0065207 · Cited by 19
Munshea, A., Sobti, R. C., Sharma, V. L., & Wanchu, A. (2019) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-019-03649-x · Cited by 18
Bayarsaikhan, S., Jagdagsuren, D., Gunchin, B., & Sandag, T. (2021) · PLoS ONE · doi:10.1371/journal.pone.0247929 · Cited by 18
Goossens, A. J. M., Cheung, K. L., Sijstermans, E., Conde, R., Rodríguez, J. L. G., & Hiligsmann, M. (2020) · Journal of Medical Economics · doi:10.1080/13696998.2020.1735398 · Cited by 18
Therapeutic Application of Genome Editing Technologies in Viral Diseases
Kim, T. H., & Lee, S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23105399 · Cited by 20
“Some viruses cause simple diseases, such as a cold, while others, such as SARS-Cov-2 (COVID-19), acquired immune deficiency syndrome (AIDS), and hepatitis can cause serious diseases.”
BackgroundInfluentialDefant, A., Mancini, I., Tomazzolli, R., & Balzarini, J. M. (2014) · Archiv der Pharmazie · doi:10.1002/ardp.201400235 · Cited by 18
HIV-1 drug discovery: targeting folded RNA structures with branched peptides
Wynn, J. E., & Santos, W. L. (2015) · Organic & Biomolecular Chemistry · doi:10.1039/c5ob00589b · Cited by 20
Exavery, A., Charles, J., Kuhlik, E., Barankena, A., Koler, A. E., Kikoyo, L., & Jere, E. (2020) · BMC Health Services Research · doi:10.1186/s12913-020-05102-y · Cited by 18
Noumi, E., & Manga, P. N. (2011) · International Journal of TROPICAL DISEASE & Health · Cited by 18
Ketotifen in HIV-infected patients: effects on body weight and release of TNF-α
Ockenga, J., Rohde, F., Süttmann, U., Herbarth, L., Ballmaier, M., & Schedel, I. (1996) · European Journal of Clinical Pharmacology · doi:10.1007/s002280050087 · Cited by 18
“Cell infection causes aberrant cytokine secretion, which is linked to a variety of disease symptoms [ 1 ].”
BackgroundTransgenic dissection of HIV genes involved in lymphoid depletion.
Tinkle, B. T., Ueda, H., Ngo, L. T., Luciw, P. A., Shaw, K., Rosen, C. A., & Jay, G. D. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119518 · Cited by 18
“Tissues analyzed include: (1) spleen; (2) salivary gland; (3) brain; (4) liver; (5) pancreas; (6) kidney; (7) uterus; (8) small intestine; (9) large intestine; (10) heart; (11) skin; (12) muscle; (13) lung.”
HIV-1 detection in endocervical swabs and mode of HIV-1 Infection
Zorr, B., Schäfer, A. P. A., Dilger, I., Habermehl, K. ‐., & Kosh, M. (1994) · The Lancet · doi:10.1016/s0140-6736(94)92052-4 · Cited by 18
Role of CD4 + T-cell proliferation in HIV infection under antiretroviral therapy
Shu, H., & Wang, L. (2012) · Journal of Mathematical Analysis and Applications · doi:10.1016/j.jmaa.2012.05.027 · Cited by 17
“Infected cells die at a rateμ2, and prior to death, each infected cell produces N new virions, of which npN are non-infectious and (1 − np)N are infectious, where np ∈ [0, 1] denotes the effectiveness of PIs with np = 1 meaning the therapy with PIs is 100% effective and no newly infectious virus particles will be prod…”
BackgroundMethodCope, F. O., Abbruzzese, B. C., Sanders, J., Metz, W., Sturms, K., Ralph, D. A., Blue, M., Zhang, J., Bracci, P. M., Bshara, W., et al. (2015) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2015.11.007 · Cited by 18
Computational investigation of the Anti-HIV activity of Chinese medicinal formula Three-Huang Powder
Hu, J., Bai, L., Chen, D., Qi-tai, X., & Southerland, W. M. (2010) · Interdisciplinary Sciences Computational Life Sciences · doi:10.1007/s12539-010-0074-1 · Cited by 17
“Acquired immunodeficiency syndrome (AIDS), a set of symptoms and infections resulting from the damage to the human immune system caused by the human immunodeficiency virus (HIV) (Weiss, 1993), has been a serious, life-threatening health problem since it was first identified in 1981.”
BackgroundOn HIV Model with Adaptive Immune Response, Two Saturated Rates and Therapy
Allali, K., Tabit, Y., & Harroudi, S. (2017) · Mathematical Modelling of Natural Phenomena · doi:10.1051/mmnp/201712501 · Cited by 17
Xuan, C., Qiao, W., Gao, J., Liu, M., Zhang, X., Cao, Y., Chen, Q., Geng, Y., & Zhou, J. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m702823200 · Cited by 17
Chetty, R., Vaithilingum, M., & Thejpal, R. (1999) · Pathology · doi:10.1080/003130299104837 · Cited by 17
Evolution of endemic pemphigus foliaceus (fogo selvagem) after HIV-1 infection
Cunha, P. R., Focaccia, R., & Diaz, L. A. (1995) · Journal of the American Academy of Dermatology · doi:10.1016/0190-9622(95)91482-x · Cited by 17
A critical analysis of the HIV-T4-cell-AIDS hypothesis
Papadopulos‐Eleopulos, E., Turner, V. F., Papadimitriou, J. M., Causer, D. A., Hedland-Thomas, B., & Page, B. A. P. (1995) · Genetica · doi:10.1007/bf01434999 · Cited by 17
Wambui, V., Kiptoo, M. K., Kinyua, J., Odera, I., Muge, E. K., Muiruri, P. N., Lihana, R. W., Kinyanjui, P., & Songok, E. M. (2012) · AIDS Research and Therapy · doi:10.1186/1742-6405-9-22 · Cited by 16
Leticia, O. I., Amadi, U., Obeagu, E. I., Andrew, A., & Ifeoma, U. E. (2014) · IOSR Journal of Dental and Medical Sciences · doi:10.9790/0853-139294101 · Cited by 16
“The CD4 count is used as a measure of immune status and disease progression, and values 200 cells/µl make the patients vulnerable to opportunistic infections and other AIDS- defining conditions.”
BackgroundInfluentialMicrobial Pre-exposure and Vectorial Competence of Anopheles Mosquitoes
Dieme, C., Rotureau, B., & Mitri, C. (2017) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2017.00508 · Cited by 16
Detection of HIV-1 antigen based on magnetic tunnel junction sensors*
Li, L., Mak, K. Y., & Zhou, Y. (2020) · Chinese Physics B · doi:10.1088/1674-1056/ab928d · Cited by 16
True story about HIV: theory of viral sequestration and reserve infection
Barasa, S. (2011) · HIV/AIDS - Research and Palliative Care · doi:10.2147/hiv.s26578 · Cited by 16
HIV-Mediated Defects in Immune Regulation
Milman, G., & D’Souza, M. P. (1994) · AIDS Research and Human Retroviruses · doi:10.1089/aid.1994.10.421 · Cited by 16
Hurwitz, S. J., & Schinazi, R. F. (2002) · Antiviral Research · doi:10.1016/s0166-3542(02)00103-1 · Cited by 16
Todd, B. J., Kedar, P. S., & Pope, J. H. (1995) · Journal of Virology · doi:10.1128/jvi.69.11.7099-7105.1995 · Cited by 16
T Cell Apoptosis in HIV Infection: Mechanisms and Relevance for AIDS Pathogenesis
Gougeon, M., Ledru, É., Lecoeur, H., & Garcia, S. (1998) · Results and problems in cell differentiation · doi:10.1007/978-3-540-69185-3_11 · Cited by 16
Pathogen within-host dynamics and disease outcome: what can we learn from insect studies?
Duneau, D., & Ferdy, J. (2022) · Current Opinion in Insect Science · doi:10.1016/j.cois.2022.100925 · Cited by 15
Guabello, G., Zuffetti, F., Ravidà, A., Deflorian, M. A., Carta, G., Saleh, M. H. A., Serroni, M., Pommer, B., Watzek, G., Francetti, L. A., et al. (2023) · Periodontology 2000 · doi:10.1111/prd.12503 · Cited by 16
“134 The virus is also capable of invading macrophages and dendritic cells, causing a progressive collapse of the immune system.”
Synthetic approaches and application of clinically approved small-molecule Anti-HIV drugs: An update
Sun, L., Nie, P., Li, L., Herdewijn, P. A., & Wang, Y. (2023) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2023.115847 · Cited by 16
Role of Type I Interferons during Mycobacterium tuberculosis and HIV Infections
Anes, E., Azevedo‐Pereira, J. M., & Pires, D. (2024) · Biomolecules · doi:10.3390/biom14070848 · Cited by 15
Ray, D., Paul, B. K., & Guchhait, N. (2013) · Journal of Photochemistry and Photobiology B Biology · doi:10.1016/j.jphotobiol.2013.06.016 · Cited by 15
“Human Immunodeficiency Virus (HIV) is a lentivirus that causes Acquired Immunodeficiency Syndrome (AIDS) [18,19], in which progressive collapse of the human immune system allows life-threatening opportunistic infections and cancers to thrive.”
BackgroundProbability of change in life: Amino acid changes in single nucleotide substitutions
Chan, K.-F., Koukouravas, S., Yeo, J. Y., Koh, D. W., & Gan, S. K. (2020) · Biosystems · doi:10.1016/j.biosystems.2020.104135 · Cited by 16
Saka, C. (2009) · Critical Reviews in Analytical Chemistry · doi:10.1080/10408340902820759 · Cited by 15
The Human Immunodeficiency Virus Type 1 Vpu Protein: Roles in Virus Release and CD4 Downregulation
Jabbar, M. A. (1995) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-78929-8_6 · Cited by 15
Immunopathology of human immunodeficiency virus infection in the gastrointestinal tract
Schneider, T., Ullrich, R., & Zeitz, M. (1997) · Springer Seminars in Immunopathology · doi:10.1007/bf00824056 · Cited by 15
Biological Characterization and Chemokine Receptor Usage of HIV Type 1 Isolates Prevalent in Brazil
Ferraro, G. A., Mello, M. A. G., Sutmöller, F., Weyenbergh, J. V., Shindo, N., Galvão‐Castro, B., & Bou‐Habib, D. C. (2001) · AIDS Research and Human Retroviruses · doi:10.1089/088922201750461294 · Cited by 15
The field theoretical ABC of epidemic dynamicsPreprint
Cacciapaglia, G., Cot, C., Morte, M. D., Hohenegger, S., Sannino, F., & Vatani, S. (2021) · arXiv (Cornell University) · doi:10.48550/arxiv.2101.11399 · Cited by 20
Roy, A., Banerjee, R., & Basak, S. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.01083 · Cited by 16
Ornano, L., Feroci, M., Guarcini, L., Venditti, A., & Bianco, A. (2018) · Studies in natural products chemistry · doi:10.1016/b978-0-444-64058-1.00006-6 · Cited by 14
Ocular Manifestations in HIV Positive and AIDS Patients in Nepal
Purushottam, J., Thakur, A. K., Choudhary, M., Sharma, S., & Shah, D. N. (2012) · International Journal of Clinical Medicine · doi:10.4236/ijcm.2012.31003 · Cited by 14
Hilleman, M. R. (1995) · Vaccine · doi:10.1016/0264-410x(95)00114-g · Cited by 14
Torres, Medrano, F. J., Rey, Calderón, E. J., Sánchez‐Quijano, Lissen, & Leal (1998) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.1998.00368.x · Cited by 14
AZT and related compounds—a theoretical study
Ciuffo, G. M., Santillán, M. B., Estrada, M. R., Yamı́n, L. J., & Jáuregui, E. A. (1998) · Journal of Molecular Structure THEOCHEM · doi:10.1016/s0166-1280(97)00273-x · Cited by 14
Heim, A., Grumbach, I. M., Hake, S., Müller, G., Pring‐Åkerblom, P., Mall, G., & Figulla, H. (1997) · Journal of Medical Virology · doi:10.1002/(sici)1096-9071(199711)53:3<255::aid-jmv13>3.0.co;2-g · Cited by 25
Metadata
- Authors
- Weiss, R. A.
- Affiliations
- Institute of Cancer Research (GB)
- Corresponding author
- Weiss, Robin A.
- ORCID
- Weiss, Robin A.
- Venue
- Science
- Published
- 1993-05-28
- Volume
- 260
- Issue
- 5112
- Pages
- 1273-1279
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2096110335
- Cited by
- 680
- References
- 130
- Citations by year
- 2026: 7 · 2025: 8 · 2024: 15 · 2023: 16 · 2022: 36 · 2021: 26 · 2020: 28 · 2019: 21 · 2018: 24 · 2017: 19 · 2016: 28 · 2015: 40 · 2014: 42 · 2013: 33 · 2012: 37
- FWCI
- 4.08
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
- Health Sciences › Medicine › Infectious Diseases › HIV-related health complications and treatments
- Health Sciences › Medicine › Infectious Diseases › HIV/AIDS Research and Interventions
- Keywords
- HIV pathogenesis, AIDS, HIV tropism, apoptosis, macrophages, dendritic cells, viral latency, autoimmune disease, immunodeficiency
- MeSH terms
- Acquired Immunodeficiency Syndrome, Animals, Antigenic Variation, Autoimmune Diseases, Dendritic Cells, HIV, Humans, Macrophages, T-Lymphocytes, Genetic Variation, Virulence, HIV Antigens, HIV Infections
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.